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Abstract. In this paper, we present the use of atlas-based indexes of
abnormality for the quantification of cardiac resynchronization therapy
(CRT) outcome in terms of motion. We build an atlas of normal motion
from 21 healthy volunteers to which we compare 88 CRT candidates
before and after the therapy. Abnormal motion is quantified locally in
time and space using a statistical distance to normality, and changes
induced by the therapy are related with clinical measurements of CRT
outcome. Results correlate with recent clinical hypothesis about CRT
response, namely that the correction of specific mechanisms responsible
for cardiac dyssynchrony conditions the response to the therapy.
1 Introduction
Cardiac resynchronization therapy (CRT) has become one of the main treat-
ments for improving the condition of patients with advanced heart failure [1].
However, around 30% of the patients implanted with a CRT device fail to clini-
cally respond (around 50% concerning echocardiographic response) [2]. Measur-
ing mechanical dyssynchrony was recently targeted by a large number of trials,
looking for a better selection parameter that could outperform the criteria cur-
rently used in clinical practice (symptomatic heart failure with long QRS length
and low ejection fraction) [3].
Single dyssynchrony indexes based on echocardiographic images showed low
predictive value, mainly due to their poor reproducibility in a multi-center con-
text [4]. In addition, the choice of a single parametric approach discards the
complexity of the mechanisms responsible for the dyssynchrony of each patient,
which explains such a low predictive value [5]. A mechanism-based patient selec-
tion strategy has recently been proposed in [6], and contrasts with the previous
approaches. The authors first classified patients into specific etiologies of me-
chanical dyssynchrony, and then studied the response of each class. They con-
cluded that CRT response mainly depends on the ability to correct these specific
abnormal mechanisms. Such a strategy also confirmed that understanding the
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patho-physiological mechanisms amenable to CRT may result more optimal for
patient selection than arbitrarily relying on the currently established selection
criteria.
Despite these conclusions, the classification of patients and the observations
made after the therapy largely relied on visual observations, which questions
their reproducibility. More novel methods based on myocardial deformation have
also been proposed to study abnormal patterns associated with dyssynchrony [7]
[8], but their use in a CRT context is also limited by the reproducibility of the
measurements. Higher reproducibility can be achieved by accurately synchro-
nizing patient data to a common spatiotemporal reference anatomy. Patient
comparison in terms of cardiac motion and deformation was proposed in [9], [10]
and [11], using the framework of statistical atlases. In particular, an atlas-based
pipeline for the quantification of myocardial motion abnormalities has recently
been described in [12]. This pipeline characterized myocardial velocities of the
studied patients according to their distance to normality, in a similar fashion
than proposed in [13] for the detection of brain abnormalities. The technique
was evaluated in the context of CRT, using a reduced set of patients with one
clear specific pattern related to left ventricle (LV) dyssynchrony, namely septal
flash (SF) [6].
In this work, we apply this framework to a large database of CRT candidates
with a wide spectrum of ventricular dyssynchrony. Our aim is to demonstrate
the added value of such an atlas-based distance to normality for the study of
response to CRT. We use the local abnormality indexes proposed in [12] to
accurately quantify improvements in wall motion induced by CRT. We finally
relate the changes in local abnormalities with information about CRT outcome,
in order to understand the causes of non-response to the therapy.
2 Methods
2.1 Patient population
For the present study, data was collected from 21 healthy volunteers, and 88
patients that were candidates for CRT based on current international clinical
guidelines (ejection fraction < 35%, QRS duration > 120ms, and NYHA classi-
fication III-IV). The study protocol was approved by our local ethics committee
and written informed consent was obtained from all patients. The baseline char-
acteristics for these subjects are summarized in Tab. 1. Clinical response was
defined at follow-up, as an increase ≥ 10% in the 6 min walking test as com-
pared to baseline, or a NYHA functional class reduction ≥ 1 point, in alive
patients without heart transplantation. Echocardiographic response was defined
as a reduction ≥ 15% in the LV end-systolic volume [2], as measured by one
experienced observer. Patients who died or had heart transplantation during the
study were considered as non-responders.
Echocardiographic (2D US) sequences in a zoomed-in 4-chamber view were
acquired for all these subjects, using a commercially available system (Vivid
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CRT candidates Volunteers
Baseline Follow-up
Age (years) 68 ± 9 30 ± 5
Male gender 64 (73 %) 14 (67 %)
QRS width (ms) 178 ± 29 . 81 ± 10
6 min walking test (m) 289 ± 82 399 ± 130 .
NYHA funcional class I 0 15 (17 %) 21 (100 %)
II 23 (26 %) 49 (56 %) 0
III 56 (64 %) 19 (22 %) 0
IV 7 (8 %) 0 0
LV end-diastolic volume (mL) 247 ± 88 212 ± 78 104 ± 27
LV end-systolic volume (mL) 186 ± 76 147 ± 66 41 ± 9
LV ejection fraction (%) 25 ± 8 33 ± 9 60 ± 5
Table 1: Clinical and echocardiographic characteristics for the population of CRT
candidates and for the set of volunteers.
7, General Electric, Milwaukee, WI, USA). The examination was performed at
baseline (OFF), 24-72 hours after device implantation (ON) and at follow-up
(FU), which corresponded in average to 11 ± 2 months after the implant. The
sequences were acquired with a breath-hold constraint to minimize the influence
of respiratory motion. Resolution was optimized during the acquisition of healthy
subjects sequences, and corresponds to an average frame rate of 60 frames/s and
a pixel size of 0.24×0.24 mm2. The temporal resolution of the sequences is lower
for the set of CRT candidates (around half the frame rate), as they have dilated
hearts and therefore require the use of a broader US sector. Their average pixel
size is 0.26× 0.26 mm2.
The choice of using 2D US and in particular the 4-chamber view was lead by
the fact that this view is the one used in clinical routine for the assessment of
fast abnormal motion patterns related to LV dyssynchrony, as described in [6].
However, the concepts developed in this paper could readily be applied to 3D US
and other imaging modalities once the required temporal resolution is available in
standard clinical acquisition protocols. The use of real-time 3D echocardiography
[14] [15] is particularly of interest to capture out-of-plane motion, which may
increase the accuracy of the proposed analysis, and extend it to specific 3D
motion patterns currently not captured by our method, such as torsion.
2.2 Atlas-based abnormality indexes
The atlas pipeline described in [12] was applied on the 4-chamber sequences of
the two populations described in Sec. 2.1. The choice of a reference among the
set of healthy volunteers was addressed using the group-wise normalized mutual
information metric proposed in [16], and criteria based on image quality (LV fully
visible along the whole sequence, and low heart rate to achieve a higher temporal
resolution of the atlas). Statistics on myocardial velocities were computed locally
in time and space, at every anatomical location (x, t) of the reference anatomy.
Normal motion was first quantified by computing the average and covariance
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Fig. 1: Left: Normalized evolution of the abnormality indexes of one CRT candidate,
versus the size of the atlas population. Average over the cardiac cycle and the septal
segments (basal inferoseptal [BI], mid inferoseptal [MI], and apical septal [AS]). Er-
ror bars represent the standard deviation over 100 random combinations of Ns < N
subjects. Right: values above which this evolution stabilizes to its final value ±5%
(dashed line), per cardiac segment and temporal window of the cardiac cycle. Average
± standard deviation values over a set of 14 CRT candidates.
of myocardial velocities for the set of healthy volunteers. Motion abnormalities
were then computed for each individual (both volunteers [using leave-one-out
cross-correlation] and CRT candidates) by calculating a statistical distance to
the velocity distribution of the atlas population (Hotelling’s T -square statistic).
This computation returned a p-value at every location (x, t) of the myocardial
wall, low p-value meaning high degree of abnormality. As these abnormality
maps are defined on a 2D+t space, one way of visualizing them is to unfold
the LV wall around its medial line and to use time as a second dimension. The
representation of the p-value in this space is similar to M-mode echocardiographic
images, classically used to visualize wall motion over time. Examples of this
representation are given in Fig. 2, focusing on the septum region.
3 Relevance of the atlas population
The computation of a distance to normality assumes that we can trust the atlas
population as being representative of normality. In this study, the atlas popula-
tion has non-dilated hearts, no antecedent of cardiac dysfunction, and its baseline
characteristics match with the values found in the literature for a population of
patients with normal cardiac function [17]. In addition, this population is rela-
tively young (age 30 ± 5 years), which means its cardiac function is preserved
from lower efficiency raising up when subjects become older.
Number of subjects To justify that the statistics are not biased due to the number
of subjects in the atlas population (N = 21), we computed the evolution of
the abnormality index (p-value) depending on the number of subjects Ns < N
involved in its computation. This experiment is summarized in Fig. 1, in which
the indexes were computed for a reduced set of 14 CRT candidates at each
spatiotemporal location (x, t). These values were normalized towards the value
obtained for the largest atlas population, so that the evolution is represented in
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(%) Segment SW LF
vρ
BI 89.6± 7.4 17.2± 5.0
MI 90.2± 7.4 17.0± 5.3
AS 90.3± 7.3 16.8± 5.0
vθ
BI 90.9± 7.5 15.9± 4.7
MI 91.2± 7.3 15.6± 4.7
AS 90.2± 7.4 16.7± 5.2
randn(21, 10000) 95.2± 0.3 13.1± 3.1
Table 2: Shapiro-Wilk (SW) and Lilliefors (LF) tests for the distribution of myocardial
velocities from 21 healthy volunteers, at each septal segment. Both components of
velocities (radial vρ and longitudinal vθ) were treated independently. Bottom line:
generation of 21 normally distributed random numbers, repeated 10000 times.
the same magnitude scale (%). The plot on the left represents this evolution for
the three septal segments of one CRT candidate. For each value of Ns < N , the
experiment was repeated for 100 random combinations of Ns subjects (vertical
error bars). In each spatiotemporal region, the number of subjects above which
this evolution stabilizes to its final value ±5% is summarized in the table on the
right (average ± standard deviation over the set of 14 CRT candidates). Based
on these values, we can reasonably trust an atlas built with all the available
population of subjects (21 volunteers).
Statistical distribution assumptions The p-value used for the quantification of
motion abnormalities is computed from the Hotelling’s T -square statistic, under
the assumption that the distribution of myocardial velocities over the set of the
21 volunteers is gaussian. We computed the Shapiro-Wilk and the Lilliefors tests
at each location (x, t) to justify this assumption. The results are summarized in
Tab. 2, which shows the average values and standard deviation of these tests
over the three septal segments, for both components of the velocities treated
independently. The last line presents the values of these tests for the generation
of 21 normally distributed random numbers, repeated 10000 times. Based on
these values, we can reasonably consider that the distribution of velocities is
gaussian at each point (x, t).
4 Clinical outcome after CRT
4.1 Atlas-based quantification of CRT outcome
We computed p-value maps of abnormality for the set of 88 CRT candidates,
as described in Sec. 2.2. These maps are illustrated in Fig. 2 at baseline and
follow-up, focusing on the septum region for three candidates. The p-value is
represented in logarithmic scale, and pondered by the sign of radial velocity
vρ at the same location (x, t). This mode of representation highlights inward
and outward motion of the septum: blue color represents high abnormality with
inward motion of the septum, red color being high abnormality for an outward
motion. Characteristic abnormality patterns are visible on these three patients
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Fig. 2: Abnormality maps in the septal region (vertical axis) for three CRT candidates,
at baseline and follow-up: two with SF (top and middle, inward and outward events of
SF being indicated by the black arrows), and one with left-right interaction (bottom).
The color scale encodes the amount of p-value in logarithmic scale, pondered by the
sign of the radial velocity. The vertical line indicates the end of the IVC period.
before the therapy, and can be related to specific types of dyssynchrony: the
patients at top and middle rows show a fast succession of blue/red color during
the IVC period, corresponding to the inward/outward events of SF. This pattern
is not visible anymore on the maps at follow-up. In contrast, the bottom row
patient has only inward abnormality during the IVC, corresponding to a left-
right interaction dyssynchrony. This pattern, despite a slight reduction, is still
visible at follow-up.
4.2 Relation between abnormality reduction and CRT outcome
The follow-up parameters for the set of CRT candidates are displayed in Tab. 1.
One patient died during the study, and was therefore considered as non-responder.
This patient had SF. Among the 87 remaining patients, experimented clinicians
visually detected SF at baseline for 58 of them (67%). This pattern was still
present after the therapy for 7 patients (8%). The amount of responders and
non-responders for these populations is summarized in Tab. 3.
Regional abnormalities were then compared to CRT outcome for the whole
set of CRT candidates, looking for differences between responders and non-
responders. Boxplots in Fig. 3 represent the average of the abnormality indexes
over temporal intervals of the cardiac cycle and the three septal segments. The
indexes were computed at baseline (OFF), after implant (ON), and at follow-up
(FU). Indexes for the atlas population are displayed in gray. In this figure, we
mainly observe a reduction of systolic abnormalities (IVC and Systole\IVC),
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Clinical
R NR
Echo
R 42 7
NR 30 9
Clinical
R NR
Echo
R 36 5
NR 15 3
Clinical
R NR
Echo
R 3 2
NR 2 0
88 CRT candidates 59 SF (OFF) 7 SF (FU)
Table 3: Clinical and echocardiographic responders (R) and non-responders (NR)
among the set of 88 CRT candidates, the set of 59 patients with SF detected at baseline
(58 survived), and the 7 patients for which SF is still present after the therapy.
at basal inferoseptal and mid inferoseptal levels. Responders show a slightly
higher reduction of abnormalities at mid inferoseptal level during the IVC. How-
ever, abnormality changes before and after CRT are similar for both responders
and non-responders at the other spatiotemporal regions, showing that the ther-
apy improves the motion and the coordination of the cardiac chambers in both
groups. This also suggests that global computations of abnormality and in gen-
eral of dyssynchrony cannot distinguish between responders and non-responders.
Such a conclusion echoes the clinical scepticism about the limited value of single
dyssynchrony indexes for the study of CRT response [4] [5].
As a consequence, we specifically looked at the evolution of abnormalities
corresponding to SF, with the underlying objective of confirming the hypothesis
that the reduction of specific abnormal patterns may be a better predictor of
CRT response. This comparison is illustrated in Fig. 4, for the set of 58 patients
who were visually diagnosed as SF at baseline, and for which FU information
is available. The displayed points represent the average of the abnormality over
the whole septum, and over the temporal windows corresponding to the inward
(IN ) and outward (OUT ) events of SF, defined as:
IN = {t ∈ IV C ∣∣ vρ(t) < 0 , t < OUT }
OUT = {t ∈ IV C ∣∣ vρ(t) > 0 , t > IN}
In this figure, we observe a large reduction of SF abnormalities for the whole
set of responders, confirming that a correction of this specific pattern stands for
a good predictor of CRT response. As a comparison, in [6], all the patients for
which SF was corrected by CRT were responders.
In our study, there were 7 non-responders among the SF population (12 %),
for which a case by case examination helps understanding the reasons for non-
response: 2 conserved the SF pattern after the therapy (cross symbols on Fig.4);
1 had still highly abnormal dyssynchronous motion, even if SF was resolved;
1 had ambiguous SF at baseline; 2 showed an increase in the 6 min walking
test that was not enough to pass the threshold for being considered as clinical
responder; and 1 fails to respond without any of these reasons.
Limitations Myocardial velocities were computed under a small displacements
hypothesis and assuming stationarity between the acquired frames, as justified
in [12]. This partially limits artifacts resulting from differences in temporal res-
olution between the set of healthy volunteers and CRT candidates respectively.
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Fig. 3: Comparison of regional abnormality indexes (p-value in logarithmic scale) at
baseline (OFF), after implant (ON), and at follow-up (FU). Clustering between re-
sponders (R) and non-responders (NR). Average over specific temporal intervals of the
cardiac cycle (columns) and septal segments (rows).
The use of 2D+t diffeomorphic tracking of the anatomy [15] will be included
to our pipeline in further work to reach better accuracy along the continuous
timescale.
In this study, results are displayed against clinical response. The observa-
tions made with echocardiographic response lead to less conclusions. This can
be interpreted by the fact that CRT is able to correct motion abnormalities
and therefore improving patient condition (clinical response), without necessar-
ily reversing cardiac remodelling (echocardiographic response). Complementary
details discussing the relevance of clinical and echocardiographic response can
be found in [2].
5 Conclusion
In this paper, we demonstrated the use of atlas-based abnormality indexes for
the local quantification of cardiac motion improvements induced by CRT, which
is particularly relevant for the understanding of CRT outcome. The conclusions
from this work correlate with the hypothesis demonstrated in recent clinical
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Fig. 4: Comparison of abnormality indexes (p-value in logarithmic scale) for the inward
(IN) and outward (OUT) events of SF, at baseline (OFF) and follow-up (FU). Average
over the IVC period and the whole septum. Cross symbols indicate patients for which
SF is still observed at FU.
trials, namely that the reduction of specific patterns of dyssynchrony conditions
the response to CRT. The prediction of response based on baseline data will
be studied in further work, and will include the comparison of individuals to
groups of patients for which response is known. Future work will also extend the
analysis to strain measurements, as the presence of local infarction might affect
CRT response, and is not currently taken into account by indexes focusing on
motion only.
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